Literature DB >> 1458763

Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

G M Pacifici1, A Viani.   

Abstract

The available techniques for the investigation of drug binding to plasma and tissues protein are reviewed and the advantages and disadvantages of the various techniques stated. A comparison of different plasma protein binding techniques is made which shows that the size of the unbound fraction of drug may be influenced by the method used. Protein binding may be assayed by methods including equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration, binding to albumin microspheres and circular dichroism. Tissue binding techniques can involve testing binding to isolated organs, tissue slices, homogenates and isolated subcellular particles. Details of the available methods to compute pharmacokinetic constants are given. Stereoselective binding has been investigated for a limited number of drugs and the difference in the binding of 2 enantiomers is usually modest. The measurement of the binding constants is often required to characterise the drug-protein interaction. Mathematical and graphical methods to compute the pharmacokinetic parameters are discussed. The implications of binding on the volume of distribution and clearance of drugs are examined.

Mesh:

Substances:

Year:  1992        PMID: 1458763     DOI: 10.2165/00003088-199223060-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  196 in total

1.  Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements.

Authors:  T Sjödin; N Roosdorp; I Sjöholm
Journal:  Biochem Pharmacol       Date:  1976-10-01       Impact factor: 5.858

Review 2.  Diseases and drug protein binding.

Authors:  J P Tillement; F Lhoste; J F Giudicelli
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

3.  Tissue fractionation in neurobiochemistry: an analytical tool or a source of artifacts.

Authors:  P Laduron
Journal:  Int Rev Neurobiol       Date:  1977       Impact factor: 3.230

4.  Tissue binding of drugs.

Authors:  M Gibaldi; P J McNamara
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

5.  Characterization of drug distribution and binding competition by two-chamber and multi-chamber distribution dialysis.

Authors:  M H Bickel; R M Raaflaub; M Hellmüller; E J Stauffer
Journal:  J Pharm Sci       Date:  1987-01       Impact factor: 3.534

6.  Subcellular distribution of digoxin-H3 in isolated guinea-pig and rat hearts.

Authors:  S Dutta; S Goswami; J O Lindower; B H Marks
Journal:  J Pharmacol Exp Ther       Date:  1968-02       Impact factor: 4.030

Review 7.  The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy.

Authors:  R Wise
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

8.  Determination and prediction of tissue binding of prednisolone in the rabbit.

Authors:  N Khalafallah; W J Jusko
Journal:  J Pharm Sci       Date:  1984-03       Impact factor: 3.534

9.  Protein binding of chloroquine enantiomers and desethylchloroquine.

Authors:  D Ofori-Adjei; O Ericsson; B Lindström; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

10.  Theophylline tissue partitioning and volume of distribution in normal and dietary-induced obese rats.

Authors:  L Y Shum; W J Jusko
Journal:  Biopharm Drug Dispos       Date:  1987 Jul-Aug       Impact factor: 1.627

View more
  30 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

2.  Pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem, in healthy male Caucasian volunteers.

Authors:  Takahiro Shibayama; Yoko Matsushita; Takashi Hirota; Toshihiko Ikeda; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

3.  Determination of the folding of proteins as a function of denaturants, osmolytes or ligands using circular dichroism.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

5.  Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats.

Authors:  E F Foote; C E Halstenson
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.

Authors:  O Borgå; B Borgå
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

7.  Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals.

Authors:  Takahiro Shibayama; Yoko Matsushita; Kenji Kawai; Takashi Hirota; Toshihiko Ikeda; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

Review 8.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

9.  In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia.

Authors:  Olivier Kretz; H Markus Weiss; Martin M Schumacher; Gerhard Gross
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

10.  Modulation of nonspecific binding in ultrafiltration protein binding studies.

Authors:  Kyoung-Jin Lee; Rachel Mower; Tom Hollenbeck; Jesus Castelo; Nikole Johnson; Perry Gordon; Patrick J Sinko; Kevin Holme; Yong-Hee Lee
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.